Notably, the inhibitor of NLRP3 inflammasome, MCC950, was able to block ox‐LDL‐induced pyroptosis, suggesting that MCC950 could be used as a promising treatment for atherosclerosis.146. This evidence concerns the gene NLRP3 and atherosclerosis.